RAS signaling pathways, mutations and their role in colorectal cancer

A genetic model for colorectal tumorigenesis

Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · see citing works

Molecular Basis of Colorectal Cancer

Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052 · see citing works

Ras, PI(3)K and mTOR signalling controls tumour cell growth

Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019 · see citing works

Molecular Genetics of Colorectal Cancer

Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805 · see citing works

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591 · see citing works

Cancer Research Communications

Calura, E., Fruscio, R., Paracchini, L., Bignotti, E., Martini, P., Sales, G., Beltrame, L., Clivio, L., Ceppi, L., Di Marino, M., et al. (2021) · doi:10.1158/1078-0432 · Cited by 1,537 · see citing works

The PI3K Pathway As Drug Target in Human Cancer

Courtney, K. D., Corcoran, R. B., & Engelman, J. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3641 · Cited by 1,235 · see citing works

The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner

Joseph, E. W., Pratilas, C. A., Poulikakos, P. I., Tadi, M., Wang, W., Taylor, B. S., Halilovic, E., Persaud, Y., Xing, F., Viale, A. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008990107 · Cited by 446 · see citing works

The RASSF1A tumor suppressor

Donninger, H., Vos, M. D., & Clark, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 442 · see citing works

Prevalence and Heterogeneity of <i>KRAS, BRAF</i>, and <i>PIK3CA</i> Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases

Baldus, S. E., Schaefer, K.-L., Engers, R., Hartleb, D., Stoecklein, N. H., & Gabbert, H. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2446 · Cited by 432 · see citing works

Signaling Interplay in Ras Superfamily Function

Mitin, N., Rossman, K. L., & Der, C. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.010 · Cited by 402 · see citing works

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Reuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300 · see citing works

New insight into BRAF mutations in cancer

Dhomen, N. S., & Marais, R. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.005 · Cited by 277 · see citing works

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

Ortiz-Vega, S., Khokhlatchev, A. V., Nedwidek, M., Zhang, X., Dammann, R., Pfeifer, G. P., & Avruch, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205192 · Cited by 209 · see citing works

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR

Heinemann, V., Stintzing, S., Kirchner, T., Boeck, S. H., & Jung, A. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.11.005 · Cited by 203 · see citing works

Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival

Nitti, D., Belluco, C., Montesco, M. C., Bertorelle, R., Pian, P. P. D., Fassina, A., Ninfo, V., Chieco‐Bianchi, L., & Lise, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10165-4 · Cited by 182 · see citing works

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Rizzo, S., Bronte, G., Fanale, D., Corsini, L. R., Silvestris, N., Santini, D., Gulotta, G., Bazan, V., Gebbia, N., Fulfaro, F., et al. (2010) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(10)70021-9 · Cited by 163 · see citing works

KRAS and BRAF: drug targets and predictive biomarkers

Vakiani, E., & Solit, D. B. (2010) · The Journal of Pathology · doi:10.1002/path.2796 · Cited by 158 · see citing works

CHOP Enhancement of Gene Transcription by Interactions with Jun/Fos AP-1 Complex Proteins

Ubeda, M., Vallejo, M., & Habener, J. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7589 · Cited by 141 · see citing works

HER 2/neu protein expression in colorectal cancer

Schuell, B., Gruenberger, T., Scheithauer, W., Zielinski, C. C., & Wrba, F. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-123 · Cited by 132 · see citing works

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

Yokota, T. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012799014968 · Cited by 127 · see citing works

Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation

Gallinger, S., Aronson, M. D., Shayan, K., Ratcliffe, E. M., Gerstle, J. T., Parkin, P. C., Rothenmund, H., Croitoru, M. E., Baumann, E., Durie, P. R., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.008 · Cited by 125 · see citing works

TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer

Merchant, N. B., Voskresensky, I. V., Rogers, C. M., LaFleur, B., Dempsey, P. J., Graves‐Deal, R., Revetta, F. L., Foutch, A. C., Rothenberg, M. L., Washington, M. K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1216 · Cited by 107 · see citing works

Detection of BRAF V600E mutation by pyrosequencing

Tan, Y. H., Liu, Y., Eu, K. W., Ang, P. W., Li, W. Q., Salto‐Tellez, M., Iacopetta, B. J., & Soong, R. (2008) · Pathology · doi:10.1080/00313020801911512 · Cited by 98 · see citing works

Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair

Oki, E., Oda, S., Maehara, Y., & Sugimachi, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202583 · Cited by 70 · see citing works

Colorectal cancer and RASSF family—A special emphasis on RASSF1A

Fernandes, M. S., Carneiro, F., Oliveíra, C., & Seruca, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27696 · Cited by 66 · see citing works

Predictive and Prognostic Biomarkers for Targeted Therapy in Metastatic Colorectal Cancer

Asghar, U. S., Hawkes, E. A., & Cunningham, D. (2010) · Clinical Colorectal Cancer · doi:10.3816/ccc.2010.n.040 · Cited by 61 · see citing works

Colorectal cancer

Ballinger, A., & Anggiansah, C. (2007) · BMJ · doi:10.1136/bmj.39321.527384.be · Cited by 57 · see citing works

RAS Signaling in Colorectal Carcinomas through Alteration of RAS, RAF, NF1, and/or RASSF1A

Ahlquist, T. C., Bottillo, I., Danielsen, S. A., Meling, G. I., Rognum, T. O., Lind, G. E., Dallapiccola, B., & Lothe, R. A. (2008) · Neoplasia · doi:10.1593/neo.08312 · Cited by 56 · see citing works

An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer

Nandan, M. O., & Yang, V. W. (2011) · Current Colorectal Cancer Reports · doi:10.1007/s11888-011-0086-1 · Cited by 47 · see citing works

NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer

Čaćev, T. (2005) · Gut · doi:10.1136/gut.2004.053348 · Cited by 47 · see citing works

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Reuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655.h8001655_1655_1669 · Cited by 29 · see citing works

492 Core Ras Pathway Signaling in Human Colorectal Cancers Revealed by Isogenic Modeling of NF1, KRas and BRAF Mutations

Ali, M. A., & Sjöblom, T. (2012) · European Journal of Cancer · doi:10.1016/s0959-8049(12)71162-0 · Cited by 1 · see citing works

pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks

Ülgen, E., Özışık, O., & Sezerman, O. U. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00858 · Cited by 456 · see citing works

Biomarkers in Cancer Detection, Diagnosis, and Prognosis

Das, S., Dey, M. K., Devireddy, R. V., & Gartia, M. R. (2023) · Sensors · doi:10.3390/s24010037 · Cited by 445 · see citing works

RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression

Rezatabar, S., Karimian, A., Rameshknia, V., Parsian, H., Majidinia, M., Kopi, T. A., Bishayee, A., Sadeghinia, A., Yousefi, M., Monirialamdari, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28334 · Cited by 343 · see citing works

Hedgehog/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease

Sigafoos, A. N., Paradise, B. D., & Fernández-Zapico, M. E. (2021) · Cancers · doi:10.3390/cancers13143410 · Cited by 245 · see citing works

LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions

Barbagallo, C., Brex, D., Caponnetto, A., Cirnigliaro, M., Scalia, M., Magnano, A., Caltabiano, R., Barbagallo, D., Biondi, A., Cappellani, A., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.009 · Cited by 222 · see citing works

Conceptual Evolution of Cell Signaling

Nair, A., Chauhan, P. S., Saha, B., & Kubatzky, K. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133292 · Cited by 218 · see citing works

The Importance of Being PI3K in the RAS Signaling Network

Cuesta, C., Arévalo-Alameda, C., & Castellano, E. (2021) · Genes · doi:10.3390/genes12071094 · Cited by 123 · see citing works

Emerging microRNAs in cancer diagnosis, progression, and immune surveillance

Harrandah, A. M., Mora-Rodríguez, R. A., & Chan, E. K. L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.019 · Cited by 98 · see citing works

miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay — A review

Elrebehy, M. A., Al-Saeed, S., Gamal, S., El‐Sayed, A., Ahmed, A. A., Waheed, O., Ismail, A., El‐Mahdy, H. A., Sallam, A.-A. M., & Doghish, A. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.06.134 · Cited by 83 · see citing works

Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer

Shaikh, M., Shinde, Y., Pawara, R. H., Noolvi, M. N., Surana, S. J., Ahmad, I., & Patel, H. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00876 · Cited by 81 · see citing works

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

Vakana, E., Pratt, S. E., Blosser, W. D., Dowless, M. S., Simpson, N., Yuan, X., Jaken, S., Manro, J. R., Stephens, J. R., Zhang, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14002 · Cited by 70 · see citing works

Ellagic acid as a potent anticancer drug: A comprehensive review on in vitro, in vivo, in silico, and drug delivery studies

Mohammadinejad, A., Mohajeri, T., Aleyaghoob, G., Heidarian, F., & Oskuee, R. K. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2288 · Cited by 65 · see citing works

A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis

Hu, F., Zeng, W., & Liu, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225720 · Cited by 64 · see citing works

Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study

Jauhri, M., Bhatnagar, A., Gupta, S., BP, M., Minhas, S., Shokeen, Y., & Aggarwal, S. (2017) · Tumor Biology · doi:10.1177/1010428317692265 · Cited by 57 · see citing works

Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes

Singh, S. P., Bhaskar, R., Ghosh, S., Yarlagadda, B., Singh, D. K. K., Verma, P., Sengupta, S., Mladenov, M. I., Hadzi‐Petrushev, N., Stojchevski, R., et al. (2025) · Cancers · doi:10.3390/cancers17071082 · Cited by 55 · see citing works

Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics Approach

Patra, R., Das, N. C., & Mukherjee, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.608313 · Cited by 50 · see citing works

Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis

Marusiak, A. A., Stephenson, N. L., Baik, H., Trotter, E. W., Li, Y., Blyth, K., Mason, S. M., Chapman, P., Puto, L. A., Read, J. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0701-t · Cited by 49 · see citing works

Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy

Sami, S. A., Darwish, N. H. E., Barile, A. N. M., & Mousa, S. A. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0694-6 · Cited by 49 · see citing works

Lectins as mitosis stimulating factors: Briefly reviewed

de Carvalho, E. V. M. M., de Oliveira, W. F., Coelho, L. C. B. B., & Correia, M. T. D. S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.003 · Cited by 48 · see citing works

Therapeutic targeting of Ras/Raf/MAPK pathway by natural products: A systematic and mechanistic approach for neurodegeneration

Gravandi, M. M., Abdian, S., Tahvilian, M., Iranpanah, A., Moradi, S. Z., Fakhri, S., & Echeverría, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154821 · Cited by 47 · see citing works

Targeting the RAS upstream and downstream signaling pathway for cancer treatment

Hossain, M. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176727 · Cited by 47 · see citing works

Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy

Klochkov, S. G., Евгеньевна, Н. М., Yarla, N. S., Parvathaneni, M., Sharma, B., Tarasov, V. V., Barreto, G. E., Бачурин, С. О., Ashraf, G. M., & Aliev, G. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.010 · Cited by 46 · see citing works

In vitro characterization of spheres derived from colorectal cancer cell lines

Olejniczak-Kęder, A., Szaryńska, M., & Kmieć, Z. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4206 · Cited by 45 · see citing works

Highlights on Specific Biological Targets; Cyclin-Dependent Kinases, Epidermal Growth Factor Receptors, Ras Protein, and Cancer Stem Cells in Anticancer Drug Development

Hawash, M. (2019) · Drug Research · doi:10.1055/a-0898-7347 · Cited by 45 · see citing works

Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis

Hisrich, B. V., Young, R. B., Sansone, A. M., Bowens, Z., Green, L. J., Lessey, B. A., & Blenda, A. V. (2020) · Biomolecules · doi:10.3390/biom10020230 · Cited by 41 · see citing works

Paradoxical effects of statins on endothelial and cancer cells: the impact of concentrations

Ahmadi, Y., Fard, J. K., Ghafoor, D. D., Eid, A. H., & Sahebkar, A. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02890-1 · Cited by 39 · see citing works

Emerging methods and techniques for cancer biomarker discovery

Dakal, T. C., Dhakar, R., Beura, A., Moar, K., Maurya, P. K., Sharma, N. K., Ranga, V., & Kumar, A. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155567 · Cited by 39 · see citing works

Monoterpenoids: An upcoming class of therapeutic agents for modulating cancer metastasis

Mathur, A., Meena, A., & Luqman, S. (2023) · Phytotherapy Research · doi:10.1002/ptr.8081 · Cited by 33 · see citing works

Autocrine hGH stimulates oncogenicity, epithelial-mesenchymal transition and cancer stem cell-like behavior in human colorectal carcinoma

Wang, J.-J., Chong, Q.-Y., Sun, X.-B., You, M., Pandey, V., Chen, Y.-J., Zhuang, Q.-S., Liu, D., Ma, L., Wu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21812 · Cited by 32 · see citing works

Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer

Keshinro, A. O., Vanderbilt, C., Kim, J. K., Fırat, C., Chen, C., Yaeger, R. D., Ganesh, K., Segal, N. H., Gönen, M., Shia, J., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00456 · Cited by 32 · see citing works

Phospholipase Cδ1 induces E-cadherin expression and suppresses malignancy in colorectal cancer cells

Satow, R., Hirano, T., Batori, R., Nakamura, T., Murayama, Y., & Fukami, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405374111 · Cited by 31 · see citing works

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors

Varela-Guruceaga, M., Tejada-Solís, S., García-Moure, M., Fueyo-Margareto, J., Gomez‐Manzano, C., Patiño‐García, A., & Alonso, M. M. (2018) · Cancers · doi:10.3390/cancers10070226 · Cited by 29 · see citing works

Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer

Bakhsh, T., Alhazmi, S., Farsi, A., Yusuf, A., Alharthi, A., Qahl, S. H., Alghamdi, M. A., Alzahrani, F. A., Elgaddar, O., Ibrahim, M. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-58536-3 · Cited by 28 · see citing works

Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression

Fonseca, A., Ramalhete, S., Mestre, A., das Neves, R. P., Marreiros, A., Castelo‐Branco, P., & Roberto, V. P. (2021) · Aging · doi:10.18632/aging.203556 · Cited by 28 · see citing works

Identification of genes critical for inducing ulcerative colitis and exploring their tumorigenic potential in human colorectal carcinoma

Patra, R., Dey, A. K., & Mukherjee, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289064 · Cited by 27 · see citing works

Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance)

Morales‐Oyarvide, V., Yuan, C., Babić, A., Zhang, S., Niedzwiecki, D., Brand-Miller, J. C., Sampson-Kent, L., Ye, X., Li, Y., Saltz, L. B., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy098 · Cited by 27 · see citing works

Molecular characterization of colorectal cancer using whole‐exome sequencing in a Taiwanese population

Chang, Y., Lee, C., Ke, T., Chang, C., Chao, D., Huang, H., & Chang, J. (2019) · Cancer Medicine · doi:10.1002/cam4.2282 · Cited by 25 · see citing works

Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs

Rath, S., Perikala, V., Jena, A. B., & Dandapat, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112095 · Cited by 25 · see citing works

Genome-wide Analysis Reveals DNA Methylation Alterations in Obesity Associated with High Risk of Colorectal Cancer

Dong, L., Ma, L., Ma, G. H., & Ren, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-41616-0 · Cited by 25 · see citing works

Impact of Cellular Genetic Make-up on Colorectal Cancer Cell Lines Response to Ellagic Acid: Implications of small interfering RNA

Yousef, A. I., El-Masry, O. S., & Abdel-Mohsen, M. A. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.2.743 · Cited by 24 · see citing works

Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients

Poulsen, T. S., de Oliveira, D. V. N. P., Espersen, M. L. M., Klarskov, L. L., Skovrider‐Ruminski, W., & Høgdall, E. V. S. (2020) · Apmis · doi:10.1111/apm.13091 · Cited by 23 · see citing works

Transcriptional Profiles of Skeletal Muscle Associated With Increasing Severity of White Striping in Commercial Broilers

Malila, Y., Uengwetwanit, T., Arayamethakorn, S., Srimarut, Y., Thanatsang, K. V., Soglia, F., Strasburg, G. M., Rungrassamee, W., & Visessanguan, W. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00580 · Cited by 22 · see citing works

Diterpenoid C of Radix Curcumae: An inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway

Shen, Y., Lü, B., Zhang, S., & Ma, Z. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2013.879907 · Cited by 21 · see citing works

Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue

Johnston, L., Power, M., Sloan, P., Long, A. K., Silmon, A., Chaffey, B. T., Lisgo, A. J., Little, L., Vercauteren, E., Steiniche, T., et al. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204629 · Cited by 21 · see citing works

Inducible Intestine-Specific Expression of kras Triggers Intestinal Tumorigenesis In Transgenic Zebrafish

Lu, J., Raghuram, D., Fong, P.-S. A., & Gong, Z. (2018) · Neoplasia · doi:10.1016/j.neo.2018.10.002 · Cited by 20 · see citing works

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility

Shahjahani, M., Hadad, E. H., Azizidoost, S., Nezhad, K. C., & Shahrabi, S. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.389 · Cited by 20 · see citing works

Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer

Lee, J. J., Jain, V., & Amaravadi, R. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212402 · Cited by 20 · see citing works

Significance of histone methyltransferase SETDB 1 expression in colon adenocarcinoma

Ho, Y., Lin, Y., Huang, Y., Chang, J., Yeh, K., Lin, L., Gong, Z., Tzeng, T., & Lu, J. (2017) · Apmis · doi:10.1111/apm.12745 · Cited by 18 · see citing works

Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer

Xu, J., Wen, J., Li, S., Shen, X., You, T., Huang, Y., Xu, C., & Zhao, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.690598 · Cited by 18 · see citing works

Miniaturized Real-Time PCR on a Q3 System for Rapid KRAS Genotyping

Guarnaccia, M., Iemmolo, R., Petralia, S., Sabrina Conoci, A., & Cavallaro, S. (2017) · Sensors · doi:10.3390/s17040831 · Cited by 17 · see citing works

Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020

de Carvalho, A. C., Ogawa, C. Y., Rodrigues, L. D. C., de Medeiros, L. S., & Veiga, T. A. M. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1897804 · Cited by 17 · see citing works

Oxygen and viruses: a breathing story

Morinet, F., Parent, M., Bergeron, C., Pillet, S., & Capron, C. (2015) · Journal of General Virology · doi:10.1099/vir.0.000172 · Cited by 17 · see citing works

Methotrexate-induced senescence of human colon cancer cells depends on p53 acetylation, but not genomic aberrations

Dąbrowska, M., Skoneczny, M., Uram, Ł. S., & Rode, W. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000731 · Cited by 16 · see citing works

β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer

Lee, H., Kim, N., Yoo, Y. J., Kim, H.-J., Jeong, E., Choi, S., Moon, S. U., Oh, S. H., Mills, G. B., Yoon, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0362-5 · Cited by 15 · see citing works

Emerging drug targets for colon cancer: A preclinical assessment

Crutcher, M. M., Baybutt, T. R., Kopenhaver, J. S., Snook, A. E., & Waldman, S. A. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2039119 · Cited by 15 · see citing works

Genome-wide methylation analysis identifies novel prognostic methylation markers in colon adenocarcinoma

Xue, W., Wu, X., Wang, F., Han, P., & Cui, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.043 · Cited by 15 · see citing works

KRAS-associated microRNAs in colorectal cancer

Ibrahim, H., & Lim, Y. C. (2020) · Oncology Reviews · doi:10.4081/oncol.2020.454 · Cited by 14 · see citing works

Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker

Bell, P. D., & Pai, R. K. (2022) · Histopathology · doi:10.1111/his.14713 · Cited by 14 · see citing works

Translational research of new developments in targeted therapy of colorectal cancer

Yang, L., Atakhanova, N. E., Arellano, M. T. C., Mohamed, M. Y., Hani, T., Fahdil, A. A., Castillo-Acobo, R. Y., Juyal, A., Hussein, A. K., Amin, A. H., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154888 · Cited by 14 · see citing works

Microvesicles mediate sorafenib resistance in liver cancer cells through attenuating p53 and enhancing FOXM1 expression

Ali, D. J., He, C., Xu, H., Kumaravel, S., Sun, B., Zhou, Y., Liu, R., & Xiao, Z. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119149 · Cited by 14 · see citing works

Cbl and Cbl-b ubiquitin ligases are essential for intestinal epithelial stem cell maintenance

Zutshi, N., Mohapatra, B. C., Mondal, P., An, W., Goetz, B. T., Wang, S., Li, S., Storck, M. D., Mercer, D. F. F., Black, A. R., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109912 · Cited by 13 · see citing works

Integrated analysis of cell cycle and p53 signaling pathways related genes in breast, colorectal, lung, and pancreatic cancers: implications for prognosis and drug sensitivity for therapeutic potential

Khan, J., Ghosh, P. K., Bajpai, U., Dwivedi, K., & Saluja, D. (2024) · Discover Oncology · doi:10.1007/s12672-024-01712-8 · Cited by 13 · see citing works

Hyaluronic acid cloaked oleic acid nanoparticles inhibit MAPK signaling with sub-cellular DNA damage in colon cancer cells

Palvai, S., Kuman, M. M., & Basu, S. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00656j · Cited by 13 · see citing works

Reciprocal Graphical Models for Integrative Gene Regulatory Network Analysis

Ni, Y., Ji, Y., & Müller, P. (2017) · Bayesian Analysis · doi:10.1214/17-ba1087 · Cited by 13 · see citing works

IDENTIFICATION OF MUTANT K-RAS IN PITUITARY MACROADENOMA

Aran, V., Heringer, M., Pereira, P. J. D. M., Kasuki, L., Miranda, R. L., Andreiuolo, F. D. M., Chimelli, L. M. C., Filho, P. N., Gadelha, M. R., & Moura‐Neto, V. (2021) · Pituitary · doi:10.1007/s11102-021-01151-6 · Cited by 13 · see citing works

Hsa-miR-6165 downregulates insulin-like growth factor-1 receptor (IGF-1R) expression and enhances apoptosis in SW480 cells

Hassanlou, M., Soltani, B. M., Medlej, A. A., Kay, M., & Mowla, S. J. (2019) · Biological Chemistry · doi:10.1515/hsz-2018-0421 · Cited by 12 · see citing works

Performance of Idylla™ RAS-BRAF mutation test for formalin-fixed paraffin-embedded tissues of colorectal cancer

Makutani, Y., Sakai, K., Yamada, M., Wada, T., Chikugo, T., Satou, T., Iwasa, Y., Yamamoto, H., Velasco, M. A. D., Nishio, K., et al. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02167-z · Cited by 12 · see citing works

Innovative dual system approach for selective eradication of cancer cells using viral-based delivery of natural bacterial toxin–antitoxin system

Shapira, S., Boustanai, I., Kazanov, D., Shimon, M. B., Fokra, A., & Arber, N. (2021) · Oncogene · doi:10.1038/s41388-021-01792-8 · Cited by 11 · see citing works

Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks

Lahiri, A., Vundavilli, H., Mondal, M., Bhattacharjee, P., Decker, B., Priore, G. D., Reeves, N. P., & Datta, A. A. (2023) · IEEE Access · doi:10.1109/access.2023.3283291 · Cited by 11 · see citing works

The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function

Kumaraswamy, A., Mamidi, A., Desai, P., Sivagnanam, A., Perumalsamy, L. R., Ramakrishnan, C. V., Gromiha, M. M., Rajalingam, K., & Mahalingam, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004452 · Cited by 11 · see citing works

A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors

Jazieh, K., Molina, J. R., Allred, J. B., Yin, J., Reid, J. M., Goetz, M. P., Lim, V.-S., Kaufmann, S. H., & Adjei, A. A. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0662-1 · Cited by 11 · see citing works

Small molecule-induced simultaneous destabilization of β-catenin and RAS is an effective molecular strategy to suppress stemness of colorectal cancer cells

Cho, Y., Ro, E. J., Yoon, J.-S., Kwak, D.-K., Cho, J., Kang, D. W., Lee, H., & Choi, K. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0519-z · Cited by 11 · see citing works

RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches

Sütcüoğlu, O., Yıldırım, H. Ç., Almuradova, E., Günenç, D., & Yalçın, Ş. (2025) · Medicina · doi:10.3390/medicina61071202 · Cited by 10 · see citing works

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs)

Ma, X., Zhou, Z., Gu, S., Guo, Y., Zhou, T., Shao, R., Yan, J., Chen, W., & Shi, X. (2025) · Cancers · doi:10.3390/cancers17193142 · Cited by 10 · see citing works

The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer

Alizadeh-Sedigh, M., Mahmoodzadeh, H., Fazeli, M. S., Aghdam, M. H., & Teimoori‐Toolabi, L. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101807 · Cited by 10 · see citing works

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Huang, Q., Zhou, Y., Wang, B., Zhao, Y., Zhang, F., & Ding, B. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01297-7 · Cited by 10 · see citing works

Relevance of different prior knowledge sources for inferring gene interaction networks

Olsen, C., Bontempi, G., Emmert‐Streib, F., Quackenbush, J. F., & Haibe‐Kains, B. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00177 · Cited by 10 · see citing works

Molecular characteristics of uveal melanoma and intraocular tumors (Review)

Katopodis, P., Khalifa, M. S., & Anikin, V. (2020) · Oncology Letters · doi:10.3892/ol.2020.12270 · Cited by 10 · see citing works

Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status

Kanat, Ö., Ertaş, H., & Caner, B. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i11.418 · Cited by 10 · see citing works

Tumor-derived extracellular vesicles: Bridging communication and next-generation theranostics

Chen, J., Verdiell, A., Formoso, C., Luciano, M., Chen, C. T., & Thakur, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118815 · Cited by 9 · see citing works

Ex vivo treatment of patient biopsies as a novel method to assess colorectal tumour response to the MEK1/2 inhibitor, Selumetinib

Novo, S. M., Wedge, S. R., & Stark, L. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-12222-9 · Cited by 9 · see citing works

Evaluation of the Idylla KRAS and NRAS mutation test in colorectal cancer tissue

Zekri, J., Baghdadi, M. A., Alardati, H. A., Khallaf, H., & Kabanja, J. H. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.104270 · Cited by 9 · see citing works

Lipopolysaccharides Enhance Epithelial Hyperplasia and Tubular Adenoma in Intestine-Specific Expression of krasV12 in Transgenic Zebrafish

Lu, J., Sun, Y., Fong, P.-S. A., Lin, L., Liu, D., & Gong, Z. (2021) · Biomedicines · doi:10.3390/biomedicines9080974 · Cited by 9 · see citing works

Phospholipase C δ1 negatively regulates autophagy in colorectal cancer cells

Shimozawa, M., Anzai, S., Satow, R., & Fukami, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.098 · Cited by 8 · see citing works

Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1−/− Mice

Gladbach, Y. S., Wiegele, L., Hamed, M., Merkenschläger, A.-M., Fuellen, G., Junghanß, C., & Maletzki, C. (2019) · Cancers · doi:10.3390/cancers11101485 · Cited by 8 · see citing works

In Silico Analysis of MicroRNA Expression Data in Liver Cancer

Abu-Shahba, N., Hegazy, E., Khan, F. M., & ElHefnawi, M. (2023) · Cancer Informatics · doi:10.1177/11769351231171743 · Cited by 7 · see citing works

Enhancing an Oxidative “Trojan Horse” Action of Vitamin C with Arsenic Trioxide for Effective Suppression of KRAS-Mutant Cancers: A Promising Path at the Bedside

Burska, A. N., Ilyassova, B., Dildabek, A., Khamijan, M., Бегимбетова, Д., Molnár, F., & Sarbassov, D. D. (2022) · Cells · doi:10.3390/cells11213454 · Cited by 7 · see citing works

Understanding the mechanism of ulcerative colitis-induced colorectal cancer and revealing the potential of Dillenia Indica in its management

Paul, S., Hmar, E. B. L., & Sharma, H. K. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100161 · Cited by 6 · see citing works

A real-world pharmacovigilance study of KRAS G12C mutation inhibitors based on the food and drug administration adverse event reporting system

Wu, L., Xu, M., Li, X., Aierken, D., Yu, J., & Qin, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1418469 · Cited by 6 · see citing works

Prognostic value and biological function of LRRN4 in colorectal cancer

Xu, C., Chen, Y., Long, F., Ye, J., Li, X., Huang, Q., Yao, D., Wang, X., Zhao, J., Meng, W., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02579-x · Cited by 6 · see citing works

Identification of transcriptional regulators and signaling pathways mediating postnatal rumen growth and functional maturation in cattle

Pokhrel, B., Tan, Z., & Jiang, H. (2024) · Journal of Animal Science · doi:10.1093/jas/skae367 · Cited by 5 · see citing works

G Protein-Coupled Receptors as Potential Intercellular Communication Mediators in Trypanosomatidae

Dı́az, E., Febres-Aldana, A. J., Giammarresi, M., Silva, A., Vanegas, O., Gomes, C., & Ponte‐Sucre, A. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.812848 · Cited by 5 · see citing works

Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis

Ephraim, R., Fraser, S., Devereaux, J., Stavely, R. G., Feehan, J., Eri, R. D., Nurgali, K., & Apostolopoulos, V. (2023) · Cancers · doi:10.3390/cancers15194793 · Cited by 5 · see citing works

Translational Suppression of KRAS and NRAS via RNA G-Quadruplex-Targeting Small Molecules for Colorectal Cancer Therapy

Zheng, B., Chen, Z.-X., Wang, Y.-K., Dong, J.-P., She, M., Zheng, Y., Zeng, Y.-X., Zheng, W.-D., Long, W. S., & Wong, W. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03088 · Cited by 4 · see citing works

Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study

Chang, Y., Chen, C., Chang, S., Chang, Y., Lin, B., Chen, H., Hsieh, Y., Hsu, H., Hsieh, M., Kuan, F., et al. (2023) · Nutrients · doi:10.3390/nu15132971 · Cited by 4 · see citing works

Genet identity and season drive gene expression in outplanted Acropora palmata at different reef sites

Young, B. D., Williams, D. E., Bright, A. J., Peterson, A., Traylor‐Knowles, N., & Rosales, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-80479-y · Cited by 4 · see citing works

Overexpression of miR-21-5p as a potential pathogenesis marker for ovarian endometriosis

Mahmoud, M., WalyEldeen, A. A., samie, M. A., Sadek, A. M., ElAkhras, S., Samir, M., Ahmed, O., Sayed, R. M. S., Baiomy, A. A., Ibrahim, S., et al. (2025) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-024-00414-5 · Cited by 4 · see citing works

Assessment of KRAS and NRAS status in metastatic colorectal cancer: Experience of the National Institute of Oncology in Rabat Morocco

Mounjid, C., Agouri, H. E., Mahdi, Y., Laraqui, A., Chtati, E.-N., Ech-charif, S., Khmou, M., Bakri, Y., Souadka, A., & Khannoussi, B. E. (2022) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.30.80 · Cited by 4 · see citing works

Combinatorial Network of Transcriptional and miRNA Regulation in Colorectal Cancer

Kumar, R., Mahmoud, M. M., Tashkandi, H., Haque, S., Harakeh, S., Ponnusamy, K., & Haider, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065356 · Cited by 4 · see citing works

Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer

Carr, A., Coulter, J. A., Workman, J. A., Fay, J., Farrelly, A. M., Eustace, A. J., Bennie, L. A., Grogan, L., Breathnach, O. S., Morris, P. G., et al. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.100926 · Cited by 3 · see citing works

RAS mutations: impact on treatment outcome

Mikhail, S., & Bekaii‐Saab, T. (2013) · Colorectal Cancer · doi:10.2217/crc.13.63

RAS signalling in the colorectum in health and disease

Poulogiannis, G., Luo, F., & Arends, M. J. (2012) · Cell Communication & Adhesion · doi:10.3109/15419061.2011.649380 · Cited by 23 · see citing works

An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer

Nandan, M. O., & Yang, V. W. (2011) · Current Colorectal Cancer Reports · doi:10.1007/s11888-011-0086-1 · Cited by 47 · see citing works

RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implications

Saeed, O. A. M., Antonio Lopez-beltran, B., Fisher, K. W., Scarpelli, M., Montironi, R., Cimadamore, A., Massari, F., Santoni, M., & Liang Cheng, C. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205471 · Cited by 47 · see citing works

La voie de signalisation RAS/MAPK

Lièvre, A., & Laurent‐Puig, P. (2010) · Cancéro digest · doi:10.4267/2042/30747 · Cited by 15 · see citing works